COO
COOPER CO (COO)
NASDAQ
$66.25+$0.83 (+1.26%)
Price as of Jun 23, 2026 3:21 PM EDT
  • $12.8B
    Market Cap
  • -5.90%
    1-Year Change
  • Medical Instruments & Supplies
    Industry

Key Performance

More
  • Earnings Score: 45
  • Momentum Score: 41
  • True Yield: N/A
  • Financial Health Score: 55
TradeSmith Loading

Latest Research & News

3 Undervalued Stocks to Buy in a Rotating Market

As the stock market rotates away from mega-cap tech, three undervalued stocks offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yield; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow metrics.

02/18/2026, 12:24 PM • Investing

3 Undervalued Stocks to Buy in a Rotating Market

As the stock market rotates away from mega-cap tech, three undervalued stocks offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.

02/18/2026, 11:08 AM • Investing

3 Undervalued Stocks to Buy in a Rotating Market

As market leadership shifts and investors rotate away from mega-cap growth stocks, three undervalued companies offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.

02/18/2026, 7:38 AM • Investing

3 Undervalued Stocks to Buy in a Rotating Market

As the stock market rotates away from mega-cap growth stocks, three undervalued companies offer compelling opportunities: Keurig Dr Pepper trades at a discount to beverage peers with attractive dividend yields; Cooper Companies benefits from healthcare sector resilience with strong EPS growth prospects; and Matador Resources capitalizes on the energy sector's 21% YTD surge with robust revenue growth and cash flow generation.

02/18/2026, 6:44 AM • Investing

Assisted Reproductive Technology Market Report 2026: Opportunities, Competitive Landscape, Trends, Strategies, and Forecasts | Astute Analytica

The global ART market is projected to grow from $30.1 billion in 2024 to $60.7 billion by 2033 at a CAGR of 8.1%, driven by rising infertility prevalence, delayed parenthood, and expanding employer-sponsored fertility benefits. IVF dominates with 90% market share, while Europe leads with 35.80% of the global market. Over 450 Fortune 500 companies now offer fertility benefits, with specialized platforms facilitating over 500,000 virtual consultations in 2024.

01/27/2026, 1:41 PM • GlobeNewswire

Contact Lens Market Size to Hit USD 26.64 Billion by 2033, Driven by Rising Vision Care Awareness and Technological Advancements – SNS Insider

The global contact lens market is projected to grow from USD 18.88 billion in 2025 to USD 26.64 billion by 2033, expanding at a CAGR of 4.42%. Growth is driven by rising myopia prevalence, increasing adoption of disposable lenses, and technological advancements in silicone hydrogel materials. However, risks from eye infections and user discomfort may hinder expansion. The U.S. market leads North America with expected growth to USD 6.83 billion by 2033.

01/16/2026, 7:00 AM • GlobeNewswire

Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial

A Georgia federal judge denied Teva Pharmaceutical's request to delay the first trial in approximately 3,800 lawsuits alleging its Paragard copper IUD can fracture during removal. The trial is scheduled to proceed on January 20. The judge previously expressed concerns about Teva's five-year delay in complying with an FDA mandate to update warning labels and rejected the company's preemption defense arguments.

01/13/2026, 11:16 AM • Benzinga

CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors

CooperCompanies announced the appointment of Walt M Rosebrough, Jr., former CEO of STERIS, as an independent director effective January 3, 2026, following a cooperation agreement with activist investor Browning West. Rosebrough will join the Corporate Governance & Nominating Committee with consideration for Board Chair by end of 2026. The company also committed to appointing a new independent director with medical technology experience.

12/23/2025, 8:00 AM • GlobeNewswire

Cooper Companies Launches Portfolio Review To 'Unlock Value'

Cooper Companies reported strong Q4 earnings, beating expectations, and announced a portfolio review to unlock long-term value. The company expects positive organic growth and raised fiscal 2026 guidance.

12/05/2025, 12:19 PM • Benzinga

Stock Market Today: Dow Futures Pare Losses As Investors Await Fed's Preferred Inflation Data— Netflix Inks $82.7B Deal For Warner Bros (UPDATED)

U.S. stock futures recovered early losses ahead of the Federal Reserve's PCE inflation data. Netflix announced an $82.7 billion deal to acquire Warner Bros Discovery, while job cuts fell 53% month-over-month in November. Markets anticipate potential interest rate cuts in December.

12/05/2025, 8:33 AM • Benzinga

Stock Market Today: Dow Slips, Nasdaq Futures Gain As Investors Await Release Of Fed's Preferred Inflation Data— Netflix, Cooper Cos In Focus

U.S. stock futures fluctuated on Friday as investors anticipate the September PCE price index. Job cuts fell 53% month-over-month in November, and markets expect a potential Federal Reserve interest rate cut in December.

12/05/2025, 5:28 AM • Benzinga

Activist Investor Drops Scathing Letter, Slams Cooper's 'Growth At All Costs' Approach

Browning West, a major shareholder, criticized Cooper Companies for underperformance, weak governance, and misaligned capital allocation strategies across its CooperVision and CooperSurgical divisions.

11/20/2025, 1:40 PM • Benzinga

New Eye Tech Is Booming For Alcon, Stock Soars

Alcon reported Q3 sales of $2.59 billion, slightly missing consensus but beating earnings expectations. The company saw strong growth in surgical and vision care segments, with promising new technologies like Unity VCS and PanOptix Pro.

11/12/2025, 11:30 AM • Benzinga

Activist Investor Seeks Strategic Overhaul At Contact Lens Maker Cooper, Suggests Merger With Bausch + Lomb

Activist investor Jana Partners has taken a stake in Cooper Companies and is pushing for strategic alternatives, including a potential merger between Cooper's contact lens division and Bausch + Lomb to improve shareholder value.

10/20/2025, 10:57 AM • Benzinga

Why Cooper Companies Stock Sank by 13% Today

Cooper Companies reported Q3 fiscal 2025 revenue of $1.06 billion, slightly meeting analyst estimates but falling short of internal expectations. Despite a 6% revenue increase and 15% growth in adjusted net income, the stock dropped 13% due to lower-than-anticipated organic growth.

08/28/2025, 5:28 PM • The Motley Fool

Peers

Statistics

More
Day Range
$64.99
$66.28
$65.42
1-Year Range
$58.98
$84.32
$65.42
Latest Close$65.42
Change
-$0.49 (-0.75%)
Volume3,175,828
Market Cap$12.8B
Shares Outstanding195.0M
P/E (TTM)54.78
Diluted EPS (TTM)$1.19
Enterprise Value$15.1B

Information as of 06/22/2026

Company Profile

COOPER COMPANIES INC
COOPER COMPANIES INC
https://www.coopercos.com
$12.8B
Market Cap
$235.8M
Net Income
Sector: Healthcare
Industry: Medical Instruments & Supplies
6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583
925 460 3600

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Key Executives

  • Albert G. White
  • Daniel G. McBride
  • Brian G. Andrews
  • Holly R. Sheffield
  • Gerard H. Warner

Current Ownership Distribution

  • Institutions2.1B (57.00%)
  • Mutual Funds1.6B (42.95%)
  • Insiders1.8M (0.05%)
  • Other0 (0.00%)